Molecular requirements for T cell recognition by a major histocompatibility complex class II-restricted T cell receptor: The involvement of the fourth hypervariable loop of the Vα domain

Journal of Experimental Medicine

Volumn 189, Issue 3, 1999, Pages 509-519

  Thatte, Jayant ^a   Qadri, Ayub ^a,b   Radu, Caius ^a   Ward, E Sally ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Antigen recognition; CD4 coreceptor; Fourth hypervariable loop; T cell receptor; V domain

Indexed keywords

ALANINE; ANTIBODY; CD4 ANTIGEN; GLUTAMIC ACID; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

AMINO ACID COMPOSITION; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TERTIARY STRUCTURE; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE ACTIVATION;

ANTIGEN PRESENTATION; ANTIGENS, CD4; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MODELS, MOLECULAR; MUTATION; MYELIN BASIC PROTEINS; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; TRANSFECTION;

EID: 0033081706     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.3.509     Document Type: Article

References (71)

1. Wange, R.L., and L.E. Samelson. 1996. Complex complexes: signaling at the TCR. Immunity. 5:197-205.
2. Iwashima, M., B.A. Irving, N.S. van Oers, A.C. Chan, and A. Weiss. 1994. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science. 263:1136-1139.
3. van Oers, N.S., W. Tao, J.D. Watts, P. Johnson, R. Aebersold, and H.S. Teh. 1993. Constitutive tyrosine phosphorylation of the T cell receptor (TCR) ζ subunit: regulation of TCRζ-associated protein tyrosine kinase activity by TCRζ. Mol. Cell. Biol. 13:5771-5780.
4. Fields, B.A., B. Ober, E.L. Malchiodi, M.I. Lebedeva, B.C. Braden, X. Ysern, J.K. Kim, X. Shao, E.S. Ward, and R.A. Mariuzza. 1995. Crystal structure of the Vα domain of a T cell antigen receptor. Science. 270:1821-1824.
5. Bentley, G.A., G. Boulot, K. Karjalainen, and R.A. Mariuzza. 1995. Crystal structure of the beta chain of a T cell antigen receptor. Science. 267:1984-1987.
6. Bentley, G.A., and R.A. Mariuzza. 1996. The structure of the T cell antigen receptor. Annu. Rev. Immunol. 14:563-590.
7. Jorgensen, J.L., U. Esser, B.F. de St. Groth, P.A. Reay, and M.M. Davis. 1992. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature. 355:224-230.
8. Davis, M.M., and P.J. Bjorkman. 1988. T-cell antigen receptor genes and T-cell recognition. Nature. 334:395-398.
9. Claverie, A., A. Prochnicka-Chalufour, and L. Bougueleret. 1989. Implications of a Fab-like structure for the T-cell receptor. Immunol. Today. 10:10-13.
10. Garcia, K.C., M. Degano, R.L. Stanfield, A. Brunmark, M.R. Jackson, P.A. Peterson, L. Teyton, and I.A. Wilson. 1996. An αβ T cell receptor structure at 2.5Å and its orientation in the TCR-MHC complex. Science. 274:209-219.
11. Garboczi, D.M., P. Ghosh, U. Utz, Q.R. Fan, W.E. Biddison, and D.C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 384:134-141.
12. Garcia, K.C., M. Degano, L.R. Pease, M. Huang, P.A. Peterson, L. Teyton, and I.A. Wilson. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science. 279:1166-1172.
13. Ding, Y.H., K.J. Smith, D.N. Garboczi, U. Utz, W.E. Biddison, and D.C. Wiley. 1998. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity. 8:403-411.
14. Hong, S.C., A. Chelouche, R.H. Lin, D. Shaywitz, N.S. Braunstein, L. Glimcher, and C.A. Janeway. 1992. An MHC interaction site maps to the amino-terminal half of the T cell receptor alpha chain variable domain. Cell. 69:999-1009.
15. Sant'Angelo, D.B., G. Waterbury, P. Preston-Hurlburt, S.T. Yoon, R. Medzhitov, S.C. Hong, and C.A. Janeway. 1996. The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity. 4:367-376.
16. b molecule. Immunity. 3:573-582.
17. Lyons, D.S., S.A. Lieberman, J. Hampl, J.J. Boniface, Y. Chien, L.J. Berg, and M.M. Davis. 1996. A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity. 5:53-61.
18. Alam, S.M., P.J. Travers, J.L. Wung, W. Nasholds, S. Redpath, S.C. Jameson, and N.R. Gascoigne. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature. 381:616-620.
19. Janeway, C.A., Jr. 1992. The T cell receptor as a multicomponent signaling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10:645-674.
20. Clayton, L.K., M. Sieh, D.A. Pious, and E.L. Reinherz. 1989. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature. 339:548-551.
21. Doyle, C., and J.L. Strominger. 1987. Interaction between CD4 and class II MHC molecules mediates cell adhesion. Nature. 330:256-259.
22. lck. Cell. 55:301-308.
23. lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell. 60:755-765.
24. Luescher, I., E. Vivier, A. Layer, J. Mahieu, F. Godeau, B. Malissen, and P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature. 373:353-356.
25. Garcia, K., C. Scott, A. Brunmark, F. Carbone, P. Peterson, I. Wilson, and L. Teyton. 1996. CD8 enhances formation of stable T-cell receptor/MHC class I complexes. Nature. 384: 577-581.
26. Janeway, C.A., Jr. 1995. Ligands for T cell receptors: hard times for avidity models. Immunol. Today. 16:223-225.
27. Yoon, S.T., U. Dianzani, K. Bottomly, and C.A. Janeway. 1994. Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity. Immunity. 1:563-569.
28. Reich, Z., J.J. Boniface, D.S. Lyons, N. Borochov, E.J. Wachtel, and M.M. Davis. 1997. Ligand-specific oligomerization of T-cell receptor molecules. Nature. 387:617-620.
29. Symer, D.E., R.Z. Dintzis, D.J. Ciamond, and H.M. Dintzis. 1992. Inhibition or activation of human T cell receptor transfectants is controlled by defined, soluble antigen arrays. J. Exp. Med. 176:1421-1430.
30. Monks, C.R., B.A. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature. 395:82-86.
31. Hampl, J., Y. Chien, and M.M. Davis. 1997. CD4 augments the response of a T cell to agonist but not to antagonist ligands. Immunity. 7:379-385.
32. Madrenas, J., L.A. Chau, J. Smith, J.A. Bluestone, and R.N. Germain. 1997. The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185:219-229.
33. Konig, R., X. Shen, and R.N. Germain. 1995. Involvement of both major histocompatibility complex class II α and β chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182:779-787.
34. Madrenas, J., and R.N. Germain. 1996. Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T cell activation. Semin. Immunol. 8:83-101.
35. McKeithan, T. 1995. Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA. 92:5042-5046.
36. Rabinowitz, J.D., C. Beeson, D.S. Lyons, M.M. Davis, and H.M. McConnell. 1996. Kinetic discrimination in T-cell activation. Proc. Natl. Acad. Sci. USA. 93:1401-1405.
37. th Ed. U.S. Department of Health and Human Services, Washington, DC.
38. Manning, T.C., C.J. Schlueter, T.C. Brodnicki, E.A. Parke, J.A. Speir, K.C. Garcia, L. Teyton, I.A. Wilson, and D.M. Kranz. 1998. Alanine scanning mutagenesis of an αβ T cell receptor: mapping the energy of antigen recognition. Immunity. 8:413-425.
39. Wraith, D.C., D.E. Smilek, D.J. Mitchell, L. Steinman, and H.O. McDevitt. 1989. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy. Cell. 59:247-255.
40. Letourner, F., and B. Malissen. 1989. Derivation of a T cell hybridoma variant deprived of functional T cell receptor α and β chain transcripts reveals a non-functional α mRNA of BW5147 origin. Eur. J. Immunol. 19:2269-2274.
41. Wraith, D.C., D.E. Smilek, and S. Webb. 1991. MHC-binding peptides for immunotherapy of experimental autoimmune disease. J. Autoimmun. 5 (Suppl A):103-113.
42. Staerz, U., H.G. Rammensee, J.D. Benedetto, and M.J. Bevan. 1985. Characterisation of a murine mAb specific for an allotypic determinant on T cell antigen receptor. J. Immunol. 134:3994-4000.
43. Patten, P.A., E.P. Rock, T. Sonoda, B. Fazekas de St. Groth, J.L. Jorgenson, and M.M. Davis. 1993. Transfer of putative complementarity determining region loops of T cell receptor V domains confers toxin reactivity but not peptide/MHC specificity. J. Immunol. 150:2281-2294.
44. Ward, E.S. 1992. Secretion of T cell receptor fragments from recombinant Escherichia coli cells. J. Mol. Biol. 224:885-890.
45. Kunkel, T.A., J.D. Roberts, and R.A. Zakour. 1987. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 154:367-382.
46. Horton, R.M., H.D. Hunt, S.N. Ho, J.K. Pullen, and L.R. Pease. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene. 77:61-68.
47. Fairchild, P.J., R. Wildgoose, E. Atherton, S. Webb, and D.C. Wraith. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC molecules: a novel route for escape from tolerance induction. Int. Immunol. 5:1151-1158.
48. u. Biochemistry. 34:4874-4878.
49. Marrack, P., R. Endres, R. Shimonkevitz, A. Zlotnik, D. Dialynas, F.W. Fitch, and J. Kappler. 1983. The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product. J. Exp. Med. 158:1077-1091.
50. Wraith, D.C., B. Bruun, and P.J. Fairchild. 1992. Cross-reactive antigen recognition by an encephalitogenic T cell receptor. J. Immunol. 149:3765-3770.
51. Rothenberg, E.V. 1994. Signaling mechanisms in thymocyte selection. Curr. Opin. Immunol. 6:257-265.
52. Pullen, A.M., T. Wade, P. Marrack, and J.W. Kappler. 1990. Identification of a T cell receptor β chain that interacts with the self-superantigen Mls-1. Cell. 61:1365-1374.
53. Choi, Y., A. Herman, D. DiGiusto, T. Wade, P. Marrack, and J. Kappler. 1990. Residues of the variable region of the T-cell-receptor β-chain that interact with S. aureus superantigens. Nature. 346:471-473.
54. Fields, B.A., E.L. Malchiodi, H. Li, X. Ysern, C.V. Stauffacher, P.M. Schlievert, K. Karjalainen, and R.A. Mariuzza. 1996. Crystal structure of a T-cell receptor β-chain complexed with a superantigen. Nature. 384:188-192.
55. d peptide complexes. Immunity. 8:553-562.
56. Fischmann, T.O., G.A. Bentley, T.N. Bhat, G. Boulot, R.A. Mariuzza, S.E.V. Phillips, D. Tello, and R.J. Poljak. 1991. Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5 Å resolution. J. Biol. Chem. 266:12915-12920.
57. Tulip, W.R., J.N. Varghese, W.G. Laver, R.G. Webster, and P.M. Colman. 1992. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex. J. Mol. Biol. 227:122-148.
58. McCoy, A.J., V. Chandana-Epa, and P.M. Colman. 1997. Electrostatic complementarity at protein/protein interfaces. J. Mol. Biol. 268:570-584.
59. d-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity. 8:319-329.
60. k in complex with a dominant epitope of lysozyme. Immunity. 8:305-317.
61. u, which confers susceptibility to experimental allergic encephalomyelitis. Mol. Med. 2:181-188.
62. Miceli, M.C., P. von Hoegen, and J.R. Parnes. 1990. Adhesion versus coreceptor function of CD4 and CD8: role of the cytoplasmic tail in coreceptor activity. Proc. Natl. Acad. Sci. USA. 88:2623-2627.
63. lck association with CD4 is required for the interaction between CD4 and the TCR/ CD3 complex for optimal antigen stimulation. J. Immunol. 148:2159-2162.
64. lck with CD4 in antigen specific signal transduction in T cells. Cell. 64:511-520.
65. Xu, H., and D.R. Littman. 1993. A kinase-independent function of Lck in potentiating antigen-specific T cell activation. Cell. 74:633-643.
66. Vignali, D.A.A., R.T. Carson, B. Chang, R.S. Mittler, and J.L. Strominger. 1996. The two membrane proximal domains of CD4 interact with the T cell receptor. J. Exp. Med. 183:2097-2107.
67. Mannie, M.D., J.M. Rossier, and G.A. White. 1995. Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and non-efficacious signals during T cell antigen recognition. J. Immunol. 154:2642-2645.
68. Vidal, K., B.L. Hsu, C.B. Williams, and P.M. Allen. 1996. Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med. 183:1311-1321.
69. Viola, A., M. Salio, L. Tuosto, S. Linkert, O. Acuto, and A. Lanzavecchia. 1997. Quantitative contribution of CD4 and CD8 to T cell antigen receptor serial triggering. J. Exp. Med. 186:1775-1779.
70. Esnouf, R.M. 1997. An extensively modified version of Mol-Script that includes greatly enhanced coloring capabilities. J. Mol. Graph. 15:133-138.
71. Meritt, E.A., and M.E.P. Murphy. 1994. Raster3D Version 2.0: a program for photorealistic molecular graphics. Acta Cryst. D. 50:869-873.